Zika Virus NS1, Recombinant (Zika Virus Nonstructural Protein 1)

Catalog No : USB-367956
514.96€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Zika Virus NS1, Recombinant (Zika Virus Nonstructural Protein 1)
Catalog No USB-367956
Supplier’s Catalog No 367956
Supplier US Biologicals
Source antigen Recombinant, E. coli
Reactivity
Cross reactivity
Applications
Molecular weight 44
Storage -70°C
Other names
Grade Highly Purified
Purity ~95% (Aqueous solvent extraction and preparative electrophoresis)
Form Supplied as liquid in 50mM NaPO4, pH 7.5. No preservative added.
Reactivity life 6 months
Note For reserch purpose only
Purity ~95% (Aqueous solvent extraction and preparative electrophoresis)
Description Zika virus was first discovered in Ughanda in 1947 in monkeys infected by the virus through bites from of infected Aedes species mosquitos. Zika virus has become a highly researched disease due to increase in incidences from 2007 to 2016, when the virus spread eastward, across the Pacific Ocean to the Americas. In 2015–16 Zika virus epidemic reached pandemic levels. The Zika NS1 protein composes the majority of the virion surface and it is involved with replication, such as host cell binding and membrane fusion. Many people infected with Zika virus will have mild or no symptoms while others will have fever, rash, joint pain, or conjunctivitis. People rarely die from Zika virus. Pregnant woman can pass Zika virus to her fetus causing microcephaly and other severe fetal brain defects. Source: Recombinant protein corresponding to Zika Virus NS1, expressed in E. coli. Molecular Weight: ~44kD Assay Information: This protein binds to Zika converted human serum polyclonal antibodies and cross reacts with Dengue virus converted human serum polyclonal antibodies. Applications: Suitable for use in ELISA, Western Blot and Lateral Flow. Other applications not tested. Recommended Dilution: ELISA: 1-2ug/ml protein range for titering Dengue virus converted human polyclonal antibodies Lateral Flow: 1-2mg/ml (1-2ul/cm) Optimal dilutions to be determined by the researcher. Storage and Stability: Aliquot to avoid repeated freezing and thawing and store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.